[ CANCER RESEARCH INSTITUTE TECHNOLOGY IMPACT AWARD | RESEARCH FUNDING ]

Thumbnail

Event details

Date 15.11.2017
Category Call for proposal
Aim: This new program is designed to encourage collaboration between technology developers and clinical cancer immunologists in addressing the gap between technology development and clinical application of cancer immunotherapies. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time – developing immunotherapies that are effective for all cancer patients.
 
Eligibility:    Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.
 
The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation personalized cancer immunotherapies.
 
Funding:       USD $200,000 over two years
Successful candidates will be eligible for follow-on funding to enable established proof-of-concept technology to be further developed.
 
Deadline: 
15 Nov 2017
(Letter of Intent)
15 March 2018 (Full Proposal)
 
Application:
Letter of Intent is submitted first
Invitation to submit a Full Proposal may follow
 
Further information can be found here, along with instructions for constructing a Letter of Intent.
 
Contact the Research Office with any questions.
 

Practical information

  • General public
  • Free

Event broadcasted in

Share